NYSE - Delayed Quote USD

agilon health, inc. (AGL)

5.0000 -0.1300 (-2.53%)
At close: April 26 at 4:00 PM EDT
5.0000 0.00 (0.00%)
After hours: April 26 at 5:32 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
4,316,363.0000
4,316,363.0000
2,388,220.0000
1,521,494.0000
1,218,333.0000
Cost of Revenue
4,246,693.0000
4,246,693.0000
2,276,860.0000
1,455,750.0000
1,124,183.0000
Gross Profit
69,670.0000
69,670.0000
111,360.0000
65,744.0000
94,150.0000
Operating Expense
301,803.0000
301,803.0000
216,738.0000
437,986.0000
150,823.0000
Operating Income
-232,133.0000
-232,133.0000
-105,378.0000
-372,242.0000
-56,673.0000
Net Non Operating Interest Income Expense
-6,658.0000
-6,658.0000
-4,484.0000
-6,146.0000
-8,135.0000
Other Income Expense
44,329.0000
44,329.0000
19,192.0000
-4,588.0000
2,465.0000
Pretax Income
-194,462.0000
-194,462.0000
-90,670.0000
-382,976.0000
-62,343.0000
Tax Provision
791.0000
791.0000
1,640.0000
886.0000
865.0000
Net Income Common Stockholders
-262,596.0000
-262,596.0000
-106,553.0000
-406,487.0000
-60,052.0000
Diluted NI Available to Com Stockholders
-262,596.0000
-262,596.0000
-106,553.0000
-406,487.0000
-60,052.0000
Basic EPS
-0.64
--
-0.26
-1.09
-0.16
Diluted EPS
-0.64
--
-0.26
-1.09
-0.16
Basic Average Shares
408,917.0000
--
408,154.0000
372,931.0000
384,836.3940
Diluted Average Shares
408,917.0000
--
408,154.0000
372,931.0000
384,836.3940
Total Operating Income as Reported
-232,133.0000
-232,133.0000
-105,378.0000
-372,242.0000
-56,673.0000
Total Expenses
4,548,496.0000
4,548,496.0000
2,493,598.0000
1,893,736.0000
1,275,006.0000
Net Income from Continuing & Discontinued Operation
-262,596.0000
-262,596.0000
-106,553.0000
-406,487.0000
-60,052.0000
Normalized Income
-195,046.0000
-195,046.0000
-87,687.1800
-383,562.0000
-63,208.0000
Interest Expense
6,658.0000
6,658.0000
4,484.0000
6,146.0000
8,135.0000
Net Interest Income
-6,658.0000
-6,658.0000
-4,484.0000
-6,146.0000
-8,135.0000
EBIT
-187,804.0000
-187,804.0000
-86,186.0000
-376,830.0000
-54,208.0000
EBITDA
-167,643.0000
-167,643.0000
-72,414.0000
-362,160.0000
-40,109.0000
Reconciled Cost of Revenue
4,242,575.0000
4,242,575.0000
2,272,037.0000
1,451,564.0000
1,123,615.0000
Reconciled Depreciation
20,161.0000
20,161.0000
13,772.0000
14,670.0000
14,099.0000
Net Income from Continuing Operation Net Minority Interest
-195,046.0000
-195,046.0000
-91,999.0000
-383,562.0000
-63,208.0000
Total Unusual Items Excluding Goodwill
--
--
-5,458.0000
--
--
Total Unusual Items
--
--
-5,458.0000
--
--
Normalized EBITDA
-167,643.0000
-167,643.0000
-66,956.0000
-362,160.0000
-40,109.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
--
--
-1,146.1800
--
--
12/31/2020 - 4/15/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

LFST LifeStance Health Group, Inc.
6.20
+0.65%
 
SGRY Surgery Partners, Inc.
24.55
-1.17%
 
PIII P3 Health Partners Inc.
0.4462
-7.02%
 
AUNA Auna SA
7.06
-1.81%
 
ACHC Acadia Healthcare Company, Inc.
73.59
+0.29%
 
FMS Fresenius Medical Care AG
20.10
-0.54%
 
DVA DaVita Inc.
133.51
+0.56%
 
ASTH Astrana Health, Inc.
36.72
+0.44%
 
CHE Chemed Corporation
560.42
-2.25%
 
HCA HCA Healthcare, Inc.
306.69
-2.37%